Investment Firm Unloads Stake in Genomica | GenomeWeb

NEW YORK, Aug. 3 – An investment firm responsible in part for providing seed money for Genomica Corporation has sold its nearly 3 percent stake in the company, it said on Friday. 

Harris & Harris Group, based in New York, sold the 731,111 shares it held for a total price of $1.5 million and earned roughly $2.5 million in net proceeds.  The investment firm said it filed a total long-term net capital gain on the sale of slightly more than $1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.